Abstract
Background: A previous PET-CT imaging study of 14 bronchoconstricted asthmatic subjects showed that peripheral aerosol deposition was highly variable among subjects and lobes. The aim of this work was to identify and quantify factors responsible for this variability.
Methods: A theoretical framework was formulated to integrate four factors affecting aerosol deposition: differences in ventilation, in how air vs. aerosol distribute at each bifurcation, in the fraction of aerosol escaping feeding airways, and in the fraction of aerosol reaching the periphery that is exhaled. These factors were quantified in 12 of the subjects using PET-CT measurements of relative specific deposition sD*, relative specific ventilation sV* (measured with dynamic PET or estimated as change in expansion between two static HRCTs), average lobar expansion FVOL, and breathing frequency measured during aerosol inhalation fN.
Results: The fraction of the variance of sD* explained by sV* (0.38), by bifurcation effects (0.38), and by differences in deposition along feeding airways (0.31) were similar in magnitude. We could not directly estimate the contribution of aerosol that was exhaled. Differences in expansion did not explain any fraction of the variability in sD* among lobes. The dependence of sD* on sV* was high in subjects breathing with low fN, but weakened among those breathing faster. Finally, sD*/sV* showed positive dependence on FVOL among low fN subjects, while the dependence was negative among high fN subjects.
Conclusion: The theoretical framework allowed us to analyze experimentally measured aerosol deposition imaging data. When considering bronchoconstricted asthmatic subjects, a dynamic measurement of ventilation is required to evaluate its effect on aerosol transport. The mechanisms behind the identified effects of fN and FVOL on aerosol deposition need further study and may have important implications for aerosol therapy in subjects with heterogeneous ventilation.
Key words: : aerosol deposition, asthma, bronchoconstriction, escape fractions, sedimentation, ventilation
Introduction
The success of an inhaled therapy depends on the dose delivered to the lungs and regional deposition likely influences therapeutic effectiveness.(1,2) We previously reported PET-CT measurements showing that deposition of inhaled aerosol in bronchoconstricted asthmatic subjects was heterogeneous. The pattern of deposition that we observed included both serial differences in the fraction of aerosol retained by the central airways feeding each lobe, as well as parallel differences in the aerosol that deposited distal to these airways.(3) In the present work, we seek to understand how serial differences in airway deposition couple with other factors to achieve the parallel heterogeneity in deposition of aerosol among lobes.
Given what is known about aerosol deposition, it is likely that most of the variability in peripheral aerosol deposition among lobes, sublobes, or any set of peripheral lung regions, can be attributed to four distinct factors: 1) differences in regional ventilation,(1,4,5) 2) differences in how the aerosol and air distribute between branches in the series of bifurcations along the pathway feeding the region,(5) 3) variability in the amount of the aerosol that escapes the series of airways along that pathway,(6,7) and 4) variability in the amount of aerosol that reaches the periphery and deposits (i.e., is not exhaled).(8) Each of these mechanisms is described in greater detail below.
Because the aerosol particles are carried by airflow through the airway tree, heterogeneity in regional ventilation can generate heterogeneity in peripheral deposition.(9) When diseased regions are less ventilated than the rest of the lung, delivery of inhaled aerosol therapy may be reduced to areas where it may be most needed. For example, bronchoconstricted subjects with asthma might expect to receive lower local doses of inhaled bronchodilator or anti-inflammatory agents in ventilation defective regions. In the present work we compare the regional distribution of aerosol deposition among lobes against the corresponding distributions of ventilation estimated with two methods: one from the washout of a gas tracer during breathing as imaged with dynamic PET-CT, and the other inferred from the relative changes in volume between two lung inflation conditions as measured from static HRCT scans.
Heterogeneity in peripheral aerosol deposition may also occur due to differences in the concentration of aerosol reaching the periphery, even in lungs with uniform ventilation.(9) These concentration differences may develop by two distinct factors. One factor emerges at bifurcations when air and aerosol divide between daughter branches in unequal fractions. This may occur when aerosol entering the bifurcation is not well mixed within the cross section of the parent branch,(5) or when the inertia of the aerosol particles prevents them from following the airflow in sharp turns.
The second factor influencing the concentration of aerosol reaching peripheral regions is the fraction of aerosol that deposits along the airways that feed them. Deposition within these airways, generally by inertial impaction, reduces the concentration of aerosol reaching the periphery. The extent of the deposition within airways can vary depending on local variations in air speed, velocity profiles, and airway tree morphometry.(6,7,10)
In certain circumstances, not all of the aerosol escaping the central airways deposits in the periphery; small particles can remain in suspension and are exhaled.(8,11) When the fraction that is retained is similar among all regions of the lung, this effects the deposition but does not introduce heterogeneity. However, differences among regions in peripheral retention can lead to heterogeneity and are thus considered as a fourth source of variable peripheral deposition among regions.
In this article, we integrate these four factors into a theoretical framework that describes the processes of transport and deposition of an inhaled aerosol along the airway tree to the periphery. Using this framework we evaluate the influence of each factor based on PET-CT imaging data of lung anatomy, aerosol deposition, and ventilation in bronchoconstricted asthmatic patients. The unique ensemble of PET deposition and ventilation images along with the detailed morphology derived from multiple HRCT images3 presented here allows this information to be evaluated for the first time. The theoretical framework yields lobar indices of the sources of variability that can be used to validate the clinical applicability of patient-specific numerical models of aerosol deposition.
Nomenclature
Peripheral | Airways and lung tissue beyond the subsegmental airways |
Central | The central airways up to and including the subsegmental airways |
xs, xsl | The subscript s indicates the value x changes with subject, and the subscript sl indicates that the value x changes with both subject and lobe |
The specific deposition in the periphery of a lobe, the subject average specific deposition, and the non-dimensional ratio of | |
The specific ventilation of a lobe, the average specific ventilation of a subject, and the non-dimensional ratio of | |
The escape fractions of aerosol passing location x in inhalation of the aerosol due to impaction, sedimentation, and diffusion | |
The fraction of aerosol passing location x during inhalation of the aerosol that is not exhaled, that fraction for a given lobe, for a given subject, and the non-dimensional ratio of | |
The retention factor of aerosol passing the carina along a pathway leading to a specific lobe, or to the entire lung | |
Cx, Csl, Ccarina,s | The concentration of the aerosol in air at: location x in the airway tree, entering into the periphery of a given lobe, passing the carina of a given subject |
Dx, Vx | The cumulative aerosol that deposits past location x in the airway tree during inhalation, and the cumulative volume of air that passes that location during inhalation |
Bk | The branching factor of airway k. Describes the change of concentration between the terminus of the parent airway and the airway entrance during inhalation if the aerosol |
Ek | The escape fraction of airway k. Describes the change of concentration along an airway k during inhalation of the aerosol |
The net branching factor of a given lobe, the average for a subject, the ratio of , and this value estimated with complete retention | |
The net escape fraction of a given lobe, the average for a subject, the ratio of and this value estimated with complete retention | |
Factors of that independently effect and | |
tN,s | The nebulization time for a given subject |
D0,s, DE,s, DT,s, DP,s, DC,s | The total aerosol arriving at the carina, the exhaled fraction, the total deposited, the peripheral deposition, and the central deposition of a given subject (with a subscript sl, it is of a given lobe) |
The total average rate and volume of gas passing the carina of a given subject during inhalation | |
VL,s | The subject lung volume |
The set of airways feeding a given lobe | |
S | The set of all lobes of all subjects |
The specific inflation of a lobe, the subject average specific ventilation, and the non-dimension ratio of the | |
MLV,TLC | The mean lung volume during tidal breathing, and total lung capacity |
The total change in gas volume from the MLV to TLC HRCT image | |
Ksl | A factor that accounts for segmentation differences and the change in blood volume between the MLV to TLC HRCT images |
The fraction of subjects ventilation reaching a given lobe | |
ds, vs, ts | The distance a particle would sediment, the settling velocity, and the settling time |
QN | The inhalation flow rate |
The degree of expansion of a lobe (the gas volume/the non-gas volume) | |
The gas and non-gas (tissue and blood) volumes estimated for a given lobe in the MLV image. A subscript of TLC indicates that this was taken from the TLC image, and a subscript of s (or T) indicates that is volume of the entire lung | |
fN | The breathing frequency of a given subject during inhalation |
FEV1 | Forced expiratory volume in 1 second after a deep inhalation |
FVC | Forced vital capacity |
Methods
We begin by introducing a general theoretical framework that describes deposition in terms of four distinct parameters that can vary among lobes. Subsequently, we describe the imaging protocol and the means of evaluating these parameters in a group of bronchoconstricted asthmatic subjects.
Theoretical framework
Overview
In this section we define a general framework that may be used to isolate sources of variable deposition among lobes, or any other region of the lung periphery that is subtended by a unique airway. We begin by defining appropriate measures of deposition and ventilation that are not sensitive to differences in volume among lobes, and introduce the notions of retention fraction and aerosol concentration. We identify two factors that can influence the concentration along each airway and identify the net contribution of each factor to differences in aerosol deposition among lobes. We then collect all sources of variability into a single expression that describes lobar deposition in Equation (6). To better compare these sources of variability across different subjects, we account for differences in overall dosing, lung size, centrality of deposition, and restate the expression in nondimensional, normalized form in Equation (9). After several simplifications, we decouple the sources of variability in Equation (15).
Lobar measures of deposition and ventilation
Deposition beyond the subsegmental airways within a lobe can be characterized by a specific deposition sDsl, where the subscript s indicates the subject studied and the subscript l indicates the lobe (or any other lung region). In this article, regions beyond the subsegmental airways are referred to as peripheral regions, while more proximal regions are referred to as central airways. sDsl is defined as the aerosol deposition with a lobe's periphery normalized by the total volume of the lobe measured at the mean lung volume during the subjects' tidal breathing (MLV). The specific deposition allows for meaningful comparisons between lobes of different volumes.
The ventilation of a lobe or lung region is similarly characterized by its regional specific ventilation , defined as the ventilation of the region per unit total volume at MLV to allow comparisons between these variables and among lobes or regions of different sizes.
Retention fraction and aerosol concentration
The retention fraction ηx of a location x along the airways is the fraction of the total aerosol that passes that location during inhalation that deposits. When ventilation data is acquired in conjunction with the deposition data, the concentration Cx of aerosol in the inhaled air can be evaluated at any location x along the airway tree. This is the average concentration along the cross section during inhalation of the aerosol, and is the ratio of aerosol to air volume that passed that location. The aerosol that passed the location is found by dividing the total deposition that deposited distal to that location Dx with the retention fraction of that location ηx (to account for exhaled aerosol that did not deposit). For a cumulative volume of air Vx passing location x during inhalation:
Note the units of the concentration will be aerosol per unit volume of air. The aerosol itself can be described in terms of mass, volume, or number of particles.
Individual airway branching factors and escape fractions
When the airflow and the aerosol entering into a bifurcation split differently between daughter branches, the aerosol concentration entering a daughter the kth airway Cairway k, ent. is no longer equal to the aerosol concentration leaving the parent airway Cparent k,exit. We can therefore define a Branching Factor Bk for an airway k as:
Thus a value of Bk≠1 quantifies a change in aerosol concentration between mother and daughter airways (Fig. 1).
A second factor affecting the concentrations is the aerosol deposition along airways; as aerosol deposits along an airway wall, the concentration of aerosol in suspension is reduced.(6) The concentration of the aerosol leaving an airway, Cairway k, exit, and that entering it, Cairway k, ent. (Fig. 1), can be used to define an escape fraction, EK, as the ratio of these concentrations:
Note that because the volume of air entering and exiting an airway is identical, the escape fraction can be determined without knowing the ventilation. By combining Equations (2) and (3), it can be shown that the product of Bk and Ek is the ratio of Cairway k, exit to Cparent k, exit :
Net branching factors and net escape fractions
The path between the carina and the periphery of each lobe includes a series of bifurcations and airways that partition and trap the aerosol. For a lobe of a subject we can calculate the ratio of average aerosol concentrations between that leaving the subsegmental airways of that lobe Csl to that entering the tracheal carina Ccarina,s. Thus, for a set of airways ψsl leading to a specific lobe of given subject the net escape fraction can be written in terms of the product of branching factor and escape fractions:
Note that the product is a net branching factor that characterizes the effect of the mismatch between air and aerosol division at bifurcations on the lobar aerosol concentration. Similarly, the product is a net escape fraction that characterizes the effect of aerosol deposition within the airways along the pathway to the lobe. Note that to evaluate either of these metrics, the individual values of Bk and Ek of each airway along the pathway must first be evaluated.
Expressing specific deposition in terms of sources of variability
The lobar specific deposition of aerosol of subject s in lobe l is therefore:
The term corresponds to the cumulative volume of air that reached the periphery of the lobe during nebulization (normalized by the total volume of the lobe). The term corresponds to the concentration of aerosol entering the lobe periphery Csl, explicitly expressed in terms of the two factors influencing it. The product of the normalized volume of air and its aerosol concentration yields the cumulative aerosol delivered to the lobar periphery (per unit volume of lobe), and when multiplied by the fraction that is not exhaled ηsl, we arrive at sDsl. Note that since the nebulization time tN,s and Ccarina,s are constants for a given subject, the four remaining terms express the sources of variability of specific deposition among lobes for a given subject.
Rearranging into nondimensional form
A nondimensional form for Equation (6) can be used to compare data from subjects with different lung sizes who received different aerosol doses, different overall ventilation and deposition, and have different degrees of overall central deposition. It is also desirable to have the nondimensional variables vary about unity to simplify the analysis as is discussed below. Let us first describe the total aerosol passing a subject's carina D0,s as the sum of the deposited aerosol past the carina DT,s and the exhaled aerosol DE,s. DT,s itself can be expressed as the sum of the deposition in the periphery DP,s and that in central airways DC,s:
Using this we can expand the concentration at the carina using the definition of concentration given in Equation (1), rewritten in terms of the total deposition beyond the carina DT,s and the total average inspiratory flow through the carina :
After substituting this relationship into Equation (6), a dimensionless form can be obtained by rearranging the terms and dividing by the total lung volume VL,s, and by DP,s/DT,s:
Here the dimensionless specific deposition and ventilation are:
These are the specific deposition of each lobe normalized by the specific deposition in the entire periphery of each subject , and the specific ventilation of each lobe normalized by the specific ventilation of the entire lung for each subject . Lobar values for these numbers for each subject distribute about unity. The already dimensionless product is normalized by the ventilation weighted lung average for each subject . Thus, if is the fraction of a subject's ventilation that is delivered to a lobe, we have that:
Note that the ventilation weighted average of is unity because the branching factors do not provide a mechanism for deposition and therefore conserve the total amount of aerosol. Similarly, the already dimensionless has been normalized by the average escape fraction of the of the airway tree for each subject:
Finally, the retention fraction of each lobe has been normalized by the retention of the entire periphery of each subject :
Decoupling sources of variability
Taking the log of Equation (9) transforms the product of effects into a sum of effects. Given that all the variables have been defined to vary about unity, we can further approximate the logarithm with the first order Taylor expansion of the logarithm about unity (log(x)≈x-1)), Equation (9) can then be approximated as:
In the specific case where these four effects are independent (i.e., there is weak covariance among the terms) we arrive at a decomposition of the variance in specific deposition in terms of the variance of the four factors that independently influence it. For the set S of all lobes among all subjects:
This final equation allows us to estimate the fraction of the variance that comes from each of the four factors. This equation states that the variability in relative specific deposition is approximately the sum of the variability in relative specific ventilation, the normalized net branching factor, the normalized net escape fraction and the normalized retention fraction.
Experimental methods
Overview
This section describes the imaging technique, and the method to extract the abovementioned parameters in a group of bronchoconstricted asthmatic subjects from PET-CT images of ventilation and aerosol deposition. The imaging protocol timeline is shown in Figure 2.
Imaging protocol
The imaging protocol was completed at Massachusetts General Hospital with IRB approval (Application No. 2007P000493). Twelve asthmatic subjects were imaged with PET-CT (Biograph 64; Siemens AG). The subjects were young (average 20.1 years), predominantly female (3 male and 9 female) and not obese (BMI's less than 32 Kg/m2). All subjects had mild intermittent or mild persistent asthma as defined by the NIH Global Initiative for Asthma(12) with FEV1 and FVC≥80% predicted, fewer than daily symptoms, and peak flow or FEV1 variability of less than 30%. All subjects demonstrated reversible obstruction with inhaled albuterol (≥12% on previous spirometry).
During an initial screening visit the concentration of methacholine (MCh) required to cause a 20% drop in the subjects FEV1 (PC20) was estimated. On a second visit that same concentration was administered with five deep breaths of methacholine aerosolized by a DeVilbiss nebulizer and Rosenthal dosimeter (model 646, DeVilbiss Healthcare, Somerset, PA) with the subject in the supine position in the PET-CT camera. Three HRCT images were obtained during breath hold: one at total lung capacity (TLC) before bronchoconstriction, a second at mean lung volume (MLV) approximately 5 minutes after bronchoconstriction, and a final HRCT at TLC approximately 30 minutes after the MCh challenge.
To monitor lung volume and guide its value during imaging, a real time trace of instantaneous volume was obtained with an inductance plethysmograph (RIP) (SomnoStar PT, SensorMedics Corp, Yorba Linda, CA) and presented to the subject through video goggles. When imaging the lung at MLV with HRCT, the subject was instructed to stop breathing and hold his/her breath when the trace reached a line defining their MLV (previously determined during a 30 sec window of spontaneous breathing before the scan).
After the MLV HRCT image (16±5 min after the MCh challenge), an aerosol of 13NH3-labeled isotonic saline was generated with a vibrating mesh nebulizer (Aeroneb Solo, Aerogen, Galway, Ireland) and delivered via an Idehaler holding chamber (Aerodrug, Cedex, France) into the mouthpiece through which the subject was breathing while wearing a nose clip. The aerosol reaching the mouthpiece was previously characterized by laser diffraction as having an approximately lognormal distribution with a median aerosol diameter of 4.9 μm and a geometric standard deviation of 1.8 (4.9 μm VMD with a GSD of 1.8). This indicates that approximately 95% of the aerosol volume was between 1.5 and 15 μm.(13) While the subjects were supine in the PET-CT camera, intrapulmonary aerosol deposition was imaged with dynamic PET during the 2-min period of inhalation and the following 8 min of spontaneous breathing.
After the end of the deposition image collection (30±5 min post MCh) regional specific ventilation was assessed during a V/Q scan from the washout of a bolus of 13NN gas as described in detail elsewhere.(14) Briefly, during a V/Q scan nitrogen (13N-N) in saline solution was injected intravenously as a bolus during apnea. The poorly soluble radioactive nitrogen gas diffuses from the plasma to the alveolar airspace resulting in an intrapulmonary tracer distribution proportional to that of regional pulmonary blood flow. Following a 20 sec breath hold, the subject resumes breathing and the washout of the tracer is used to determine regional specific ventilation.
It was important to conduct the ventilation measurement as close as possible to that of deposition to minimize changes in the degree of constriction. The close proximity (15±2 min) between the deposition and ventilation images meant that there was some residual labeled aerosol that was registered as 13NN gas in the washout image. This residual activity was very small compared to the activity coming from the 13NN (<4%) and similar among lobes, and thus weakly affects .
In 9 of the 12 subjects with ventilation images, we were also able to estimate the breathing frequency during aerosol inhalation from the RIP signal; the data from the first three subjects were recorded on an older laptop, and the signals could not be recovered.
Evaluating deposition and ventilation from the images
The PET images were analyzed to quantify the anatomical location of the aerosol deposition and the alveolar ventilation. The local tracer from the deposition images was assigned to anatomical regions (ARs) using the Grayscale method previously developed.(3) This technique allowed quantification of aerosol deposition within anatomically defined portions of the central airway tree (CA) and on distal regions fed by them, after accounting for blurring of the PET image due to breathing motion, limited spatial resolution of PET, and PET-CT co-registration uncertainties. Using Apollo™ software (Vida Diagnostics, Mountain View, CA) the lung was segmented into 14 ARs, including 5 peripheral lobar regions and 9 segments of the airway tree (Fig. 3). The lung periphery included the five lobes; left upper lobe (LUL), left lower lobe (LLL), right upper lobe (RUL), right middle lobe (RML), and right lower lobe (RLL). Central airways included the bronchus intermedius (BINT), the right and left main bronchus (RMB and LMB) and the trachea (TRC), as well as five lobar central airway trees feeding each lobe that included the lobar, segmental, and subsegmental airways.
The distribution of deposition throughout the lung and airways was described as the relative specific deposition . Note that the radionuclide concentration of the aerosol must be known to evaluate from the activity within the image. However, once normalized by the average specific deposition (as in ), the relative depositions can be determined directly from the relative activities in the image.
The relative distribution of ventilation during aerosol inhalation was assumed to be equal to that measured during the subsequent 13NN washout during the V/Q scan. Voxel by voxel ventilation was estimated from the best model chosen by the Akaike Information Criterion(14) among a two-compartment model, a one compartment model, a partial gas trapping model, and a full gas trapping model. Net alveolar ventilation for each lobe was estimated as the sum of voxel products of compartment's turnover rate times its gas volume. The gas volume in each compartment within a voxel was estimated by the gas content of the voxel (measured from the CT scan at MLV) multiplied by the fraction of perfusion of the voxel that was delivered to that compartment. The voxel by voxel estimates were then distributed among lobes based on how each lobe contributed to the activity in that voxel.(3) The total ventilation of the lobe is divided by the lobe volume to identify the specific ventilation . Dividing by the average specific ventilation among all lobes in the subject yielded . Note that although this is a measure of relative alveolar specific ventilation, if the deadspace ventilation distributes in a similar way as the fresh gas,(15) this is also a measure of relative total specific ventilation.
Estimating specific inflation from 2 HRCTs
An alternative estimate of lobar ventilation distribution, similar to one used in previous studies,(15,16) uses the change in lobar volume between two static HRCT scans from MLV to TLC as a proxy for the ventilation during tidal breathing. The specific inflation was therefore:
where the V terms are the different total lung volumes post constriction and Ksl is a number close to 1 that corrects for lobar segmentation differences of the lobe between the two images. Under the assumption that differences in the tissue volume of a perfectly segmented lobe should not differ between the two images, and that changes in blood volume can be estimated from the entire lung, Ksl can be expressed in terms of the blood and tissue volumes VTissue of the lobes and lungs:
A dimensionless form for is obtained by normalizing by the average lung specific inflation , or the total lung inflation divided by the MLV lung volume:
Estimating lobar retention fractions
Lobar retention fractions could not be directly estimated from our data, nor were there values in the literature that could be directly used. However, based on global lung bolus retention data presented by Kim et al.,(8) we could estimate a global retention fraction of the periphery as a function of the settling distance ds (see details in Appendix I). A general relationship could be derived that explained 97% of the variance in the measured peripheral retention fraction among nine experiments with varying particle sizes and flow rates (Fig. 4). Given the settling distance ds that a particle of a given diameter would descend at the Stokes settling velocity vs during the average residence time in the periphery ts, we found that the retention fraction could be described by the equation:
Evaluating for the polydisperse aerosols used in our study showed that we can expect those subjects breathing at the highest frequencies during nebulization fN should show approximately 20%–60% lower average retention. The value of was highly sensitive to proximal filtering effects; when larger aerosols are selectively filtered in the upper and central airways, the retention fraction of the periphery is significantly reduced (Fig. 5).
While this population averaged and lung averaged data can provide a useful estimate of the degree of average retention among all lobes, lobar retention fractions may vary substantially between subjects and lobes. For example, expanded lobes may have reduced ηsl due to both the longer sedimentation distances and lower likelihood of impaction in the distended airways. The expansion of a lobe FVOL,sl can be defined as the total volume of gas Vgas per unit of tissue and blood volume VTissue in a lobe at MLV:
Note that FVOL,sl is a measure of the degree of regional expansion during a breath hold at MLV and is not directly related to regional tidal volume. Assessment of both fN and FVOL,sl may provide insight into retention fraction effects.
Apparent net branching factor and escape fraction
The net branching factor and net escape fraction are both functions of changes in aerosol concentration along the airway tree and are thus intricately coupled with the lobar retention fractions. If these parameters are evaluated under the assumption of complete deposition in all lobes, an apparent net branching factor and apparent net escape fraction are obtained. Appendix II demonstrates that if is defined as the retention fraction of a specific lobar pathway at the carina, then the apparent branching factor and apparent escape fraction have the following relationship with the actual values:
Note that and are both dimensionless terms that both distribute around 1 and combine to form the lobar retention fraction :
In this article we will present the apparent parameters as a proxy for the actual factors, noting that they differ from the actual factors by the and factors defined in Equation (21).
The apparent branching factors can be evaluated from PET-CT deposition and ventilation images for the first four bifurcations in the airway tree (Fig. 6) by setting ηx as unity throughout the airway tree. The apparent escape fractions can be similarly calculated up to the lobar central airways. Due to the limited spatial resolution of PET, proximal airways within each lobe, up to the subsegmental airways, had to be lumped into a single compartment with an average lobar escape fraction.
Statistical analysis
Systematic Differences Among Lobes in , and , were tested using ANOVA with repeated measures. When differences were evident at the 5% alpha level, a Holm-Sidak test for multiple comparisons was used to test for individual differences between lobes.(17) It should be noted that no further correction was made for the different ways that we divided and explored our data; all statistics are therefore exploratory and only intended to guide future studies. Variability in and was characterized using the average coefficient of variation among lobes for each subject (COVLobes), and using the COV among subjects for each lobe (COVSubjects).
Results
Typical deposition pattern
PET-CT measurement of the aerosol deposition showed a highly centralized pattern of deposition in the present data set, with 33±6% of the aerosol entering the carina depositing in the airways up to and including the subsegmental generation. The maximum intensity projections for a typical subject are presented in Figure 7.
Relationship between sD* and sV*
A global correlation between lobar ventilation and deposition for the group of subjects was found by pooling the non-dimensional results for all lobes of all subjects (Fig. 9, left). The distribution of correlated with the distribution of (Corr(sD*,sV*)=0.62, p (Corr. <0)<0.0001). The strength of subject by subject relationships varied, and these are shown in Figure 8. The average correlation coefficients Corr(sD*,sV*)s was 0.51±0.29, with the subjects breathing at slower frequencies during the aerosol nebulization fN having higher correlations between and than those breathing faster (Corr(Corr(sD*,sV*)s,fN)=−0.71, p (Corr. <0)=0.032). Additionally, as expected, subjects presenting low inter-lobar variability in deposition or in ventilation, tended to yield poor ventilation-deposition correlations (Fig. 8).
Relationship between sD* and sI*
We further compared the distribution of (derived from two static CT images at MLV and TLC) and . In contrast with , there was no significant correlation between normalized and normalized for the pooled lobar results (Fig. 9, right). However, there was a great deal of intersubject variability that was evident among subjects: some correlations were strongly negative, others strongly positive, and others did not correlate at all. This variability resulted in a low average correlation (Corr(sD*,sI*)s=0.11±0.64). Unexpectedly, these correlations were found to be a tight function of the inhalation breathing frequency, with the lower fN subjects having strong but negative relationship between and (Corr(Corr(sD*,sI*)s,fN)=0.89, p (Corr>0)=0.0012).
Relationship between sV* and sI*
We found no correlation between and among all subjects. However, we noted that the three least constricted subjects (those with the highest percent predicted FEV1 after bronchoconstriction measured during imaging) showed positive correlations between and ranging from 0.71 to 0.95. It is also noted that there was a strong negative correlation (average Corr(FVOL,sI*)s=−0.94±0.08) between the lobar degree of parenchymal expansion, FVOL,sl, measured from a single static CT at MLV, and the value of derived from the change in parenchymal expansion between the MLV and TLC scans.
Sources of variability in sD*
There was high variability in among lobes: average COVLobes of 0.335±0.082 among lobes in a subject, and an average COVSubjects 0.264±0.109 among the same lobe in different subjects. Deposition in the LLL was significantly lower than other lobes except for the RML (Fig. 10, left panel). This variability was reduced after accounting for regional differences in lobar ventilation: average COVLobes=0.277±0.067, average COVSubjects=0.214±0.105 (Fig. 10, center panel). After accounting for branching factors and a portion of the particle retention effects, the variability was further reduced: average COVLobes=0.116±0.074, average COVSubjects=0.084±0.057 (Fig. 10, right panel).
The contribution of each of the three factors to the variability in specific deposition was characterized using the Pearson Correlation Coefficient squared among the specific deposition and measurements of its influencing factors. The contribution of these three factors to the average variability in was approximately 1/3 for each factor (Table 1). However, the variances of lobar and among all lobes and subjects was about ½ of the variance of while the variance of was only 1/7 of that of (Table 2). Weak interactions were observed among the specific ventilation, the apparent net branching factors, and the apparent net escape fraction (Table 1). This suggests that the separation of the sources of variability in Equation (15), which neglected covariance between the parameters, is in fact accurate for the present data.
Table 1.
Xj | Yj | |
---|---|---|
0.38 | ||
0.38 | ||
0.31 | ||
0.01 | ||
0.02 | ||
0.04 |
Table 2.
xj | |||
---|---|---|---|
0.48 | 0.45 | 0.15 |
A relationship among fN, FVOL, and sD*/sV*
The inter-subject variability in sD*/sV* for each lobe was frequency dependent for the LLL, RLL, and RML. In Figure 11 the plots for each lobe have been ordered from left to right based on the relative degree of lobar expansion at MLV. Note the least expanded lobes (the LLL and RLL) tended to increase deposition per unit ventilation with increasing breathing frequency, while the opposite was true for the RML: the most expanded lobe of the lung.
This behavior is shown by the significant frequency dependence of the correlation between lobar FVOL,sl and sD*/sV* for the different subjects (Fig. 12, Corr(Corr(sD*/sV*, FVOL),fN)=−0.97, p (Corr. >0)<0.0001). Note that the subjects breathing at the slower fN showed strong positive correlations, while those breathing the fastest showed a strong negative relationship between sD*/sV* and FVOL.
Discussion
Key findings
We have presented a theoretical framework to quantify four mechanisms that can lead to heterogeneous aerosol deposition among lobes: differences in lobar ventilation, uneven splitting of aerosol and air at bifurcations, differences in the fraction of aerosol deposited along the feeding airways, and differences in the fraction of aerosol that reaches the periphery but escapes via exhalation. We used this framework to quantify the contribution of these four effects in a group of 12 bronchoconstricted subjects with asthma. The following observations were seen from our data: First, differences in lobar specific ventilation (measured from the turnover rate of 13NN washout) and in the apparent net branching factors each accounted for more than a third of the variability in deposition among lobes and subjects. The remaining variability was caused by differences in deposition along the feeding airways as characterized by their apparent net escape fractions.
Second, subjects breathing slowly (<9 BPM) during nebulization had a strong relationship between regional deposition and ventilation with PET, while the relationship weakened in subjects breathing more rapidly. Also in subjects breathing faster, the more expanded lobes showed lower deposition per unit ventilation than less expanded lobes, while the opposite was true for subjects breathing slowly. Lastly, differences in lobe expansion between HRCTs at two lung volumes, sometimes used as a surrogate of regional ventilation, failed to explain the variability in regional deposition across subjects.
The relationship between sD* and sV* depend on fN
Large inter-subject variability was observed in the relationship between and . These include a tendency for strong positive relationships between the two lobar measures in subjects breathing with low frequency during aerosol inhalation, and weaker positive relationships in subjects breathing at faster frequencies. It is therefore likely that the other factors besides ventilation become important at higher breathing frequencies, such as increased central impaction, increased branching factor effects, and or a more variable retention fraction.
This result is qualitatively consistent with the predictions of a recent CFD model by Darquenne et al.(9) using an idealized geometry of the human central airway tree and uniform specific ventilation among lung segments. Their results showed that the distal delivery of aerosol from the trachea to the lung segments was largely determined by the distribution on ventilation for Stokes numbers in the trachea less than 0.01. Conversely, when 10 μm particles were inhaled at flow rates 500 mL/sec, other effects besides the distribution of ventilation had a strong impact on the transport of aerosol from the trachea to the periphery. They also found that the Stokes number of the segmental airway feeding the sublobar segments explained 55% of the variance in deposition that was not otherwise explained by ventilation.
Similar quantification was attempted in the present experimental work but remained elusive; among other challenges, the polydisperse nature of the aerosol used in this study, together with uncertain proximal filtering effects, make it difficult to evaluate comparable Stokes numbers from the present data. In addition, the CFD model compares the number of monodisperse particles that escaped the central and segmental airways against the ventilation into the respective peripheral regions. The in vivo data measured here must consider that not all of the inhaled particles reaching the periphery deposit since some may be lost during exhalation. Despite these difference, the range in sD*/sV* (average COVLobes=0.277±0.067) was similar to the range in R (a measure equivalent to sD*/(sV*η*)) observed in the CFD model at a Stokes numbers in the trachea of 0.02 to 0.04. To use the present data to validate CFD models of aerosol deposition, a polydisperse aerosol should be used in the model, and the effect of incomplete deposition in the lobar periphery must be considered.
Lung disease may also influence the relationship between regional ventilation and deposition1. For example in the presence of constricted or obstructed airways can be expected to interfere with the relationship between ventilation and deposition. A narrow airway (such as in cystic fibrosis(18) or asthma(10)) both collects aerosol particles and reduces ventilation of subtended regions of the lung. Indeed, no relationship between ventilation and deposition could be found in 10 subjects with HIV infections using a 2D gamma-scintigraphy.(19) Other factors in poorly ventilated regions may lead to paradoxical increases in deposition; due to lower gas turnover rates(20) within these regions, suspended particles may have more time to sediment than in well ventilated regions. However, these paradoxical effects have only been observed after correcting for the bulk effect of reduced ventilation.(20) It is also plausible that the reduced caliber of constricted distal airways may lead to shorter sedimentation distances and allow for more complete retention.
On average, sV* accounts for a third of the variability in sD*, sI* does not
When we compared regional specific ventilation against , the dynamic ventilation measurement derived from PET accounted for more than a third of the variability in deposition among the lobes of all subjects. In contrast, the specific inflation derived from two static CT images failed to explain the variability in . This is not surprising that correlated with but not with given that the first two variables are measured during breathing and depend on dynamic factors while is based on static measurements. Presumably, the dynamic PET measure captures the reduced ventilation of slowly filling regions (that would have time to fill during the breath hold needed for CT, which ranges between 4 to 16 seconds depending on the slice). Nonetheless, in conditions where airway resistance is small may still be a reasonable surrogate of as demonstrated by the good correlation between these variables in the two least constricted subjects in this study.
A recent study of mild to moderate asthmatic, but not bronchoconstricted, subjects compared estimates of ventilation using static HRCT at two lung volumes to the deposition pattern of 1.3 μm 99mTc particles inhaled during slow tidal breathing as imaged by SPECT-CT.(16) They found that the average difference in ventilation distribution of a lobe between the static estimates and the 99mTc deposition were only 3%. This measure would be approximately 12% of the lobar ventilation (only four effective lobes were used in that analysis). In contrast, our measurements using injected 13NN with PET-CT with bronchoconstricted asthmatic subjects during spontaneous tidal breathing showed average differences of 22% between and , and no overall correlation between these variables. This finding is consistent with earlier measurements from our laboratory,(15) which concluded that in asthmatic subjects and in bronchoconstricted normal subjects, static measures or regional inflation from HRCT did not correlate with the sub-lobar distribution of specific ventilation. The two measures correlated only among normal subjects before bronchoconstriction.
However, if dynamic effects were the only explanation for our findings, one could have expected that the correlation between and would have been highest and positive in those subjects breathing with the lowest fN. Remarkably, the opposite was true: and had the highest positive correlations in those subjects breathing with the highest fN, while in subjects breathing with low fN the correlation was strongly negative. It is therefore likely that the signs and magnitude of the correlations between an in subjects breathing at different frequencies are reflecting the strong negative relationship between and FVOL,sl. For example, it is plausible that the observed fN-dependent correlations between and could reflect the effects of distal airway lumen caliber (∼FVOL,sl) and aerosol residence time in the periphery (∼1/ fN) on peripheral aerosol retention rather than direct effects of specific ventilation.
If CFD models of aerosol inhalation during tidal breathing are to reflect clinical reality in diseased or bronchoconstricted lungs, boundary conditions determined from measurement that are sensitive to the dynamic effects of slowly filling and emptying regions may be required. However, it is still possible that lobar inflation patterns measured from two static CT scans could yield representative boundary conditions for airflow in CFD models of healthy lungs, or in diseased lungs with slow and deep breaths.
Explaining the relationship among fN, FVOL, and sD*/sV*
Among subjects breathing at very low (<9 BPM) and very high frequencies (>17 BPM) the expansion of the lobes was strongly related to the deposition not explained by ventilation, albeit the direction of the effect depended on breathing frequency. While this signal was exceptionally strong, it is not easily interpreted. One possible explanation is as follows: lobes with high FVOL,sl are expected to have dilated airways with reduced retention ηsl due to both the longer sedimentation distances and reduced likelihood of impaction due to slower velocities and wider turns. Additionally, the analysis based on data from Kim et al.(8) (Fig. 5) showed a 20%–60% reduced in subjects breathing with a higher fN. A reduction in . could be expected to amplify differences in caused by heterogeneous FVOL,sl, thus generating a negative correlation with the measured deposition and FVOL,sl. An alternative explanation is based on the branching effect at the junction between the RML and RLL (bifurcation 4 in Fig. 6). From the data in Figure 11, it is clear that sD*/sV* in the RML (the lobe with the highest average FVOL,sl across subjects) is inversely related with the subject's fN, while the opposite is true for the lobe with the lowest average FVOL,sl across subjects (the RLL). It could be that at higher fN, the sharp turn to the RML causes the aerosol to keep moving into the RLL. However, this theory does not explain the positive effect of fN for the LLL.
It is important to note that although these explanations are consistent with the emerging phenomenon at high fN, alone they cannot explain why those same high FVOL,sl lobes appear to be receiving greater deposition than would be expected based on their ventilation at low fN. To explain this, a certain degree of bias for a positive relationship between FVOL,sl and sD*/sV*, driven by a consistently low sD*/sV* in the LLL (a lobe that also has low FVOL,sl). This low sD*/sV* appears to be evident in the of the LLL in (Fig. 10, right panel).
Methodological limitations
A number of methodological limitations in the present study should be considered when interpreting our findings. First, the lobar retention fractions could not be measured, but are required to obtain accurate estimates of the actual net escape fractions and branching factors. Unless particle motion can be visualized, these values may need to be estimated from CFD or analytical models in which the data provided by our study could be used as input. Despite this limitation, we were able to separate apparent net branching factor and escape fractions, and to directly express in Equation (21) how heterogeneity in retention fractions among lobes causes these measures to differ from the actual branching factor and retention fractions. Additionally, using aerosol bolus data from Kim et al.,(8) we identified a relationship that estimates the overall magnitude of the peripheral retention that we could expect in the present data, and provided a means to understand how breathing frequency during inhalation affects the retention.
It was also assumed that the fine particles that escape deposition in the periphery do not significantly deposit in the central airways on their egress from their lung. While this is likely the case when only a small fraction of the aerosol is exhaled, when a significant amount of aerosol is exhaled, deposition during exhalation should be considered, particularly in the presence of flow limitation in the central airways.(21) The primary consequence of not considering this effect is an underestimation of airway escape fractions. While the theoretical framework in this presentation is thought to be generally applicable, the experimental findings are limited to the conditions and population we studied. For example, changing the nebulizer setup can influence the aerosol size distribution and deposition pattern,(22) and might also influence the contributions of different sources of variability in specific aerosol deposition.
Additional limitations in the measurements arise from the estimation of ventilation distribution. The distribution of ventilation during nebulization was assumed to be similar to the distribution of alveolar minute ventilation measured 10 minutes later (30±4.5 minutes after Mch), an assumption that could be weakened by the presence of a nebulizer circuit during the nebulizing image, and the possibility of a reduced methacholine effect during the ventilation image. While some researchers have found little change in the degree of methacholine-induced bronchoconstriction after 60 min,(23) others have found that methacholine wears off by 60% within 30 min.(24)
There are also potential errors in the estimates of that were fully explored in a previous publication.(3) The overall effect of such potential errors in and are challenging to quantify, and they are in part responsible for some of the variability in (Fig.10, central panel). However, given the high correlation between and that was observed in subjects breathing with slow frequency, and the systematic effects of fN on the relationship between FVOL,sl and , it is unlikely that these limitations invalidate our results. Also, as can be derived from the aerosol deposition pattern alone, it is insulated from errors in the ventilation estimation.
Nonsystematic measurement errors should increase variability of parameters within and across subjects. The isolation of the net escape fraction from errors in ventilation may be partially responsible for the low variability across subjects of the net escape fraction (illustrated by the low inter-subject variability in net escape fraction of a given lobe in Fig. 10, right panel). Net branching factors, on the other hand, are sensitive to errors in both the ventilation and deposition assessment, and errors in both images likely contributed to some of the variance in the net branching factors.
Clinical relevance
In this study, we evaluated the heterogeneity in aerosol deposition and ventilation in conditions similar to those expected clinically by allowing the subjects to breathe freely without attempting to control their lung volumes or breathing frequency. This technique provided us with a data set of that spanned the physiological range of breathing frequencies during nebulization. From our results it has become clear that breathing frequency and lung expansion appear to have important effects on the relationship between ventilation and aerosol deposition among subjects at a lobar level. Although these effects were not expected a priori, they provide an important basis for future experimental and numerical studies where these effects can be controlled and evaluated. The present data set can be used to identify physiologically appropriate boundary conditions for ever improving CFD models.
Despite other sources of heterogeneity, it is clear that poorly ventilated regions of the lung will generally receive a smaller fraction of the inhaled aerosol than better ventilated regions. Lower deposition might result in paradoxical effects where an inhaled bronchodilator could aggravate the discrepancy between low and high ventilated regions. This effect has been anecdotally observed with imaging in our laboratory,(25) where a single administration of bronchodilator increased the size of ventilation defects in an asthmatic subject. In the present study, several regions that received low ventilation clearly showed markedly reduced aerosol deposition, as exemplified in the extreme case presented in Figure 13.
The theoretical framework presented here has proven to be a useful tool to describe and understand parallel heterogeneity in deposition among lobes. In the bronchoconstricted asthmatic subjects studied, more than a third of this variability was caused by ventilation heterogeneity; poorly ventilated lobes tended to receive lower aerosol deposition. Breathing was not controlled during nebulization in this study, and it is expected that the deposition pattern observed after nebulization during spontaneous breathing is reflective of the type of distribution that occurs beyond laboratory walls. The relationship between ventilation and deposition has implications for the distribution of aerosol therapies in subjects with heterogeneous ventilation, and should be considered when using inhaled therapies to treat regions of poor ventilation.
In summary, heterogeneity in specific deposition among lobes can emerge from 1) differences in lobar ventilation, 2) uneven splitting of aerosol and air at bifurcations, 3) differences in the fraction of aerosol trapped by feeding airways, and 4) differences in the fraction of aerosol that is retained in the periphery and not exhaled. These effects were integrated into a theoretical framework that provided insight into measurements of deposition and ventilation in bronchoconstricted asthmatic subjects. In this data, heterogeneous specific ventilation accounted in average for more than a third of the heterogeneous specific deposition of aerosols among lobes. This relationship can cause inhaled aerosol therapy to miss poorly ventilated regions. Lobar inflation between two CT images did not show a similar relationship, suggesting that dynamic PET may provide a better estimate of ventilation for bronchoconstricted asthmatic subjects.
The remaining three factors besides ventilation that influence specific deposition appeared to be related to the inflation of the lobes during nebulization in a way that was strongly modulated by the breathing frequency during nebulization, though the mechanism for this remains somewhat unclear. Understanding the ventilation-deposition relationship at a regional level may help to develop strategies for inhaled therapies.
Appendix I
Lobar retention fractions were not available from our data. Inhalation bolus data from Kim et al.(8) were used to calculate the overall retention fraction at penetration volumes VP greater than 100 mL (about the depth of the subsegmental airways) for particle sizes dp ranging from 1–5 um, delivered at a fixed tidal volume VT of 500 mL constant inhalation speeds QN ranging from 150 to 500 mL/sec. To estimate the retention fraction, we calculated the fraction of the inhaled aerosol that deposited past 100 mL by removing the deposition in regions more proximal than 100 mL (provided in Fig. 8 of Kim et al.(8)) from the non-bolus total deposition (Table 3 of Kim et. al.(8)). We compared the deposition to the fraction of aerosol that survived the first 100 mL, which was determined by fraction exhaled in the 100 mL bolus depth experiment. The ratio of the deposited fraction to the fraction that arrived is the retention fraction.
We then calculated the distance ds that the monodisperse aerosols in each of the experiments would travel during the average residence time ts at depths greater than 100 mL if the particles traveled at the Stokes settling velocity vs.
where gravity, the density of the particle, and the viscosity of air are represented with their conventional symbols. We found that 97% of the variance among the experiments could be explained with a single parameter fit:
Note that the fit constant of 371 μm is on the order of an alveolus.
Estimating the global retention fraction in the present data set taken with polydisperse aerosols is significantly more complex. Given a particle distribution function P, the net retention fraction can be estimated as:
The particles size distribution was measured to be lognormal with a VMD of 4.9 μm and a GSD of 1.8. Larger particles are more likely to deposit in the upper airways, and the distribution reaching the periphery is expected to have a reduction in larger particles. We therefore numerically integrated the above equation for the net retention fraction for particles below several cutoff diameters (Fig. 5).
Appendix II
Apparent and actual net branching factors and escape fractions. From the theoretical framework it is clear that variability in both of these factors can influence variability in specific deposition among peripheral regions. However, our methodology does not allow measurements of regional retention fractions, and this limits our ability to measure the true branching factors and escape fractions. In the presence of incomplete peripheral aerosol retention (e.g., some portion of the aerosol is exhaled), we can only estimate an apparent concentration based on the assumption of complete retention. This apparent concentration is the concentration of aerosol that will ultimately deposit that passes location x along the airway. The apparent concentration thus does not consider aerosol particles that remain in suspension and are exhaled, and is less than or equal to the actual concentration by the retention fraction at that location. Using apparent concentration in place of actual concentration, we could derive an apparent net branching factor and apparent net escape fraction using Equations (1)–(5). These can be non-dimensionalized by the average apparent branching factor and average apparent escape fraction to arrive at and apparent net escape fraction .
In the absence of information about lobar retention fractions, it is necessary to understand how the apparent parameters (the factors that are calculated if the retention fraction is assumed to be one) relate to the actual parameters. If we consider the ratio of the escape fractions in terms of the distribution of aerosols, and then factor out the retention fractions, we arrive at our first result:
Further, can be written in terms of the non-dimensional actual and apparent factors. If we equate the two we conclude that:
By substituting our first result into this equation we conclude that:
Acknowledgments
Research reported in this publication was supported by the National Institutes of Health under award number R01HL68011. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support was provided by American Air Liquide Inc., and Aerogen is thanked for providing the vibrating mesh nebulizers
Author Disclosure Statement
This work was sponsored in part by American Air Liquide Inc. and Aerogen. However, there is no conflict of interest with these parties on any of the material presented in this paper.
References
- 1.Darquenne C: Aerosol deposition in health and disease. J Aerosol Med Pulm Drug Deliv. 2012;25:140–147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Usmani OS, Biddiscombe MF, and Barnes PJ: Regional lung deposition and bronchodilator response as a function of β2-agonist particle size. Am J Respir Crit Care Med. 2005;172:1497–1504 [DOI] [PubMed] [Google Scholar]
- 3.Greenblatt EE, Winkler T, Harris RS, Kelly VJ, Kone M, and Venegas J: Analysis of three-dimensional aerosol deposition in pharmacologically relevant terms: Beyond black or white ROIs. J Aerosol Med Pulm Drug Deliv. 2015;28:116–129 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Robertson HT, Glenny RW, Stanford D, McInnes LM, Luchtel DL, and Covert D: High-resolution maps of regional ventilation utilizing inhaled fluorescent microspheres. J Appl Physiol. 1997;82:943–953 [DOI] [PubMed] [Google Scholar]
- 5.Miyawaki S, Tawhai MH, Hoffman EA, and Lin CL: Effect of carrier gas properties on aerosol distribution in a CT-based human airway numerical model. Ann Biomed Eng. 2012;40:1495–1507 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.de Vasconcelos TF, Sapoval B, Andrade JS, Grotberg JB, Hu Y, and Filoche M: Particle capture into the lung made simple? J Appl Physiol. 2011;110:1664–1673 [DOI] [PubMed] [Google Scholar]
- 7.Chan TL, and Lippmann M: Experimental measurements and empirical modelling of the regional deposition of inhaled particles in humans. Am Indust Hygiene Assoc J. 1980;41:399–409 [DOI] [PubMed] [Google Scholar]
- 8.Kim CS, Hu S, DeWitt P, and Gerrity T: Assessment of regional deposition of inhaled particles in human lungs by serial bolus delivery method. J Appl Physiol. 1996;81:2203–2213 [DOI] [PubMed] [Google Scholar]
- 9.Darquenne C, van Ertbruggen C, and Prisk GK: Convective flow dominates aerosol delivery to the lung segments. J Appl Physiol. 2011;111:48–54 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Katz I, Majoral C, Montesantos S, Dubau C, Texereau J, Caillibotte G, and Pichelin M: Modeling the influence of the gas mixture on ventilation and aerosol deposition within pathological human lungs: Helium-oxygen vs. air. Am J Respir Crit Care Med. 2014;189:A6276 [Google Scholar]
- 11.Darquenne C, and Prisk GK: Aerosol deposition in the human respiratory tract breathing air and 80:20 heliox. J Aerosol Med. 2004;17:278–285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Asthma GIf: Global Strategy for Asthma Management and Prevention. NIH Publication; 2002 [Google Scholar]
- 13.Finlay P, Martin A, Katz I, Vecellio L, Caillibotte G, and Venegas J: Aerosol delivery from a vibrating mesh nebulizer with holding chamber in helium/oxygen versus air. J Aerosol Med Pulm Drug Deliv. 2013;26:A20 [Google Scholar]
- 14.Wellman TJ, Winkler T, Costa EL, Musch G, Harris RS, Venegas JG, and Melo MFV: Effect of regional lung inflation on ventilation heterogeneity at different length scales during mechanical ventilation of normal sheep lungs. J Appl Physiol. 2012;113:947–957 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wongviriyawong C, Harris RS, Greenblatt E, Winkler T, and Venegas JG: Peripheral resistance: A link between global airflow obstruction and regional ventilation distribution. J Appl Physiol. 2013;114:504–514 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.De Backer JW, Vos WG, Vinchurkar SC, Claes R, Drollmann A, Wulfrank D, Parizel PM, Germonpré P, and De Backer W: Validation of computational fluid dynamics in CT-based airway models with SPECT/CT. Radiology. 2010;257:854–862 [DOI] [PubMed] [Google Scholar]
- 17.G C. Anovarep: Compute the Anova for repeated measures and Holm-Sidak test for multiple comparisons if Anova is positive. 2008
- 18.Brown JS, Zeman KL, and Bennett WD: Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis. J Aerosol Med. 2001;14:443–454 [DOI] [PubMed] [Google Scholar]
- 19.O'Riordan TG, and Smaldone GC: Regional deposition and regional ventilation during inhalation of pentamidine. CHEST J. 1994;105:396–401 [DOI] [PubMed] [Google Scholar]
- 20.Trajan M, Logus J, Enns E, and Man S: Relationship between regional ventilation and aerosol deposition in tidal breathing. Am Rev Respir Dis. 1984;130:64–70 [DOI] [PubMed] [Google Scholar]
- 21.Smaldone GC: Physiological and pathological considerations for aerosol deposition: Expiration and models of deposition. J Aerosol Med. 2000;13:387–391 [DOI] [PubMed] [Google Scholar]
- 22.Sagalla RB, and Smaldone GC: Capturing the efficiency of vibrating mesh nebulizers: Minimizing upper airway deposition. J Aerosol Med Pulm Drug Deliv. 2014;27:341–348 [DOI] [PubMed] [Google Scholar]
- 23.Cartier A, Malo J, Begin P, Sestier M, and Martin R: Time course of the bronchoconstriction induced by inhaled histamine and methacholine. J Appl Physiol. 1983;54:821–826 [DOI] [PubMed] [Google Scholar]
- 24.Mannino F, Sposato B, Ricci A, Grasso D, De Clementi F, and Mariotta S: Induction and recovery phases of methacholine-induced bronchoconstriction using FEV1 according to the degree of bronchial hyperresponsiveness. Lung. 2001;179:137–145 [DOI] [PubMed] [Google Scholar]
- 25.Venegas J, Winkler T, and Harris RS: Lung physiology and aerosol deposition imaged with positron emission tomography. J Aerosol Med Pulm Drug Deliv. 2013;26:1–8 [DOI] [PubMed] [Google Scholar]